Centre for Neuromuscular Disease
- Home
- Clinical Services
- Core Activities
- Research Groups
- MRC Centre Members
- Scientific Advisory Board
- Publications
- Seminar Program
- UK Neuromuscular Translational Research Conference
- Courses and Workshops
- Studentships
- Fellowships
- Clinical Trials
- The UK National Neuromuscular Database
- Dubowitz Neuromuscular Centre
- Cochrane Neuromuscular Disease Group
- British Myology Society
- British Peripheral Nerve Society
- Industry Collaborations
- Patient Organisation Partners
- Donations
- Job Vacancies
- UK Neuromuscular Translational Research Conference 2011
- UK Neuromuscular Translational Research Conference 2010
- UK Neuromuscular Translational Research Conference 2009
- Inaugural UK Neuromuscular Translational Research Conference 2008
- Contact Us
News
2012 UK Neuromuscular Translational Research Conference
The fifth joint annual meeting of the MRC Centre for Neuromuscular Diseases and the Muscular Dystrophy Campaign will take place on Thursday 22nd - Friday 23rd March 2012 at the Centre for Life, Newcastle upon Tyne.
Third Annual Meeting of the BMS
Tuesday 6th - Wednesday 7th September 2011 at St Anne's College, Oxford.
CNMD team run the BUPA
London 10,000
On Monday 30th May Mike
Hanna headed a team from the Centre for Neuromuscular Diseases taking part in
the BUPA London 10,000 to raise funds for The National Brain Appeal [formally
the National Hospital Development Foundation (NHDF)]. All money received
will support research into serious muscle wasting neurological diseases in
the Centre for Neuromuscular Diseases.
Professor Angela Vincent
We congratulate Professor Angela Vincent, Emeritus Professor
of Neuroimmunology, University of Oxford, Professor of Neuroimmunology, UCL
Institute of Neurology and member of the Centre to her election to the
Fellowship of the Royal Society
Patient Organisation Partners
Please email z.scott@ucl.ac.uk to receive information on future events.
Patient Organisation Day 2010
6th October at Queen Square
Click here to view the meeting programme
Patient Organisation Day 2008
13th November, National Hospital for Neurology and Neurosurgery, Queen Square
The MRC Centre for Neuromuscular Diseases held its first patient organisation representatives meeting on Thursday 13th November at Queen Square.
Click here to view the programme
Partners:
Action Duchenne
www.actionduchenne.org
Association for Glycogen Storage Disease (UK)
www.agsd.org.uk
Becker United
www.beckerunited.com
CMT UK
www.cmt.org.uk
Duchenne Family Support Group
www.dfsg.org.uk
FSH-MD Support Group
www.fsh-group.org
GBS Support Group
www.gbs.org.uk
The Guillain-Barre Syndrome Support Group is a registered charity that supports those suffering from Guillain-Barre Syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and related conditions in the United Kingdom and Republic of Ireland, in particular by:
- Providing care, information, non-medical advice and other assistance to sufferers and their families
- Promoting research into the causes, prevention and treatment of the illness, and
- Advancing the education of the public and of the medical professoins concerning the illnesses, their causes, prevention and treatment
The Jennifer Trust for Spinal Muscular Atrophy
www.jtsma.org.uk
The Muscular Dystrophy Campaign
www.muscular-dystrophy.org
Myasthenia Gravis Association
www.mgauk.org
Myositis Support Group
www.myositis.org.uk
Myotonic Dystrophy Support Group
www.mdsguk.org
Myotubular Trust
www.myotubulartrust.org.uk
"The relief of disability and the extension of life for those suffering from myotubular myopathy, by promoting the study of, and research into, the treatment and cure of the muscle weakness caused by myotubular myopathy”.
The Myotubular Trust (Registered Charity No: 1113809) was set up in 2006 with the sole purpose of raising research funds to find a cure and / or treatment for myotubular myopathy. The Myotubular Trust wishes to ensure that despite the relative rarity of the condition, research into myotubular myopathy can keep pace with scientific advances being made, and on the cusp of being made, in other fields of muscle disease.
The Trust hopes to fund projects that will help find a cure and / or a treatment for any of the three types of myotubular myopathy (congenital X-linked recessive; congenital autosomal recessive; autosomal dominant), focusing on research that would not generally be funded by public or industrial funding sources. Since its inception the Trust has raised over £400,000 and made its first call for grants in September 2008.
The Trust also aims to ensure latest advances in the understanding of the condition and research progress is made available to families and clinicians as and when it becomes available. We particularly wish to ensure that clinicians are made aware of the up to date view on the prognosis for a newly diagnosed patient, to ensure that better informed decisions are made in what are often life and death situations.
Nemaline Myopathy Support Group
www.davidmcd.btinternet.co.uk
